                               SEQUENCE LISTING	

<110> CHILDREN'S MEDICAL CENTER CORPORATION
      DANA-FARBER CANCER INSTITUTE
 
<120> METHODS OF PROMOTING TISSUE GROWTH AND TISSUE REGENERATION

<130> 701039-067241-PCT

<140>
<141>

<150> 61/300,477
<151> 2010-02-02

<160> 3     

<170> PatentIn version 3.5

<210> 1
<211> 2196
<212> DNA
<213> Homo sapiens

<400> 1
ctgggcgggt catgcgccct ggccttcgcg catctcccag gttagctgcg tgtccgggtg       60

ctaggctgca gacccgccgc catgacgctg cgcgcggccg tcttcgacct tgacggggtg      120

ctggcgctgc cagcggtgtt cggcgtcctc ggccgcacgg aggaggccct ggcgctgccc      180

agaggacttc tgaatgatgc tttccagaaa gggggaccag agggtgccac tacccggctt      240

atgaaaggag agatcacact ttcccagtgg ataccactca tggaagaaaa ctgcaggaag      300

tgctccgaga ccgctaaagt ctgcctcccc aagaatttct ccataaaaga aatctttgac      360

aaggcgattt cagccagaaa gatcaaccgc cccatgctcc aggcagctct catgctcagg      420

aagaaaggat tcactactgc catcctcacc aacacctggc tggacgaccg tgctgagaga      480

gatggcctgg cccagctgat gtgtgagctg aagatgcact ttgacttcct gatagagtcg      540

tgtcaggtgg gaatggtcaa acctgaacct cagatctaca agtttctgct ggacaccctg      600

aaggccagcc ccagtgaggt cgtttttttg gatgacatcg gggctaatct gaagccagcc      660

cgtgacttgg gaatggtcac catcctggtc caggacactg acacggccct gaaagaactg      720

gagaaagtga ccggaatcca gcttctcaat accccggccc ctctgccgac ctcttgcaat      780

ccaagtgaca tgagccatgg gtacgtgaca gtaaagccca gggtccgtct gcattttgtg      840

gagctgggct ccggccctgc tgtgtgcctc tgccatggat ttcccgagag ttggtattct      900

tggaggtacc agatccctgc tctggcccag gcaggttacc gggtcctagc tatggacatg      960

aaaggctatg gagagtcatc tgctcctccc gaaatagaag aatattgcat ggaagtgtta     1020

tgtaaggaga tggtaacctt cctggataaa ctgggcctct ctcaagcagt gttcattggc     1080

catgactggg gtggcatgct ggtgtggtac atggctctct tctaccccga gagagtgagg     1140

gcggtggcca gtttgaatac tcccttcata ccagcaaatc ccaacatgtc ccctttggag     1200

agtatcaaag ccaacccagt atttgattac cagctctact tccaagaacc aggagtggct     1260

gaggctgaac tggaacagaa cctgagtcgg actttcaaaa gcctcttcag agcaagcgat     1320

gagagtgttt tatccatgca taaagtctgt gaagcgggag gactttttgt aaatagccca     1380

gaagagccca gcctcagcag gatggtcact gaggaggaaa tccagttcta tgtgcagcag     1440

ttcaagaagt ctggtttcag aggtcctcta aactggtacc gaaacatgga aaggaactgg     1500

aagtgggctt gcaaaagctt gggacggaag atcctgattc cggccctgat ggtcacggcg     1560

gagaaggact tcgtgctcgt tcctcagatg tcccagcaca tggaggactg gattccccac     1620

ctgaaaaggg gacacattga ggactgtggg cactggacac agatggacaa gccaaccgag     1680

gtgaatcaga tcctcattaa gtggctggat tctgatgccc ggaacccacc ggtggtctca     1740

aagatgtaga acgcagcgtg tgcccacgct cagcaggtgt gccatccttc cacctgctgg     1800

ggcaccattc ttagtataca gaggtggcct tacacacatc ttgcatggat ggcagcattg     1860

ttctgaaggg gtttgcagaa aaaaaagatt ttctttacat aaagtgaatc aaatttgaca     1920

ttattttaga tcccagagaa atcaggtgtg attagttctc caggcatgaa tgcatcgtcc     1980

ctttatctgt aagaaccctt agtgtcctgt agggggacag aatggggtgg ccaggtggtg     2040

atttctcttt gaccaatgca tagtttggca gaaaaatcag ccgttcattt agaagaatct     2100

tagcagagat tgggatgcct tactcaataa agctaagatg actatgctgc tggctgtctt     2160

tgttcttgga gaggtggagt gactgttcac ggagaa                               2196


<210> 2
<211> 555
<212> PRT
<213> Homo sapiens

<400> 2
Met Thr Leu Arg Ala Ala Val Phe Asp Leu Asp Gly Val Leu Ala Leu 
1               5                   10                  15      


Pro Ala Val Phe Gly Val Leu Gly Arg Thr Glu Glu Ala Leu Ala Leu 
            20                  25                  30          


Pro Arg Gly Leu Leu Asn Asp Ala Phe Gln Lys Gly Gly Pro Glu Gly 
        35                  40                  45              


Ala Thr Thr Arg Leu Met Lys Gly Glu Ile Thr Leu Ser Gln Trp Ile 
    50                  55                  60                  


Pro Leu Met Glu Glu Asn Cys Arg Lys Cys Ser Glu Thr Ala Lys Val 
65                  70                  75                  80  


Cys Leu Pro Lys Asn Phe Ser Ile Lys Glu Ile Phe Asp Lys Ala Ile 
                85                  90                  95      


Ser Ala Arg Lys Ile Asn Arg Pro Met Leu Gln Ala Ala Leu Met Leu 
            100                 105                 110         


Arg Lys Lys Gly Phe Thr Thr Ala Ile Leu Thr Asn Thr Trp Leu Asp 
        115                 120                 125             


Asp Arg Ala Glu Arg Asp Gly Leu Ala Gln Leu Met Cys Glu Leu Lys 
    130                 135                 140                 


Met His Phe Asp Phe Leu Ile Glu Ser Cys Gln Val Gly Met Val Lys 
145                 150                 155                 160 


Pro Glu Pro Gln Ile Tyr Lys Phe Leu Leu Asp Thr Leu Lys Ala Ser 
                165                 170                 175     


Pro Ser Glu Val Val Phe Leu Asp Asp Ile Gly Ala Asn Leu Lys Pro 
            180                 185                 190         


Ala Arg Asp Leu Gly Met Val Thr Ile Leu Val Gln Asp Thr Asp Thr 
        195                 200                 205             


Ala Leu Lys Glu Leu Glu Lys Val Thr Gly Ile Gln Leu Leu Asn Thr 
    210                 215                 220                 


Pro Ala Pro Leu Pro Thr Ser Cys Asn Pro Ser Asp Met Ser His Gly 
225                 230                 235                 240 


Tyr Val Thr Val Lys Pro Arg Val Arg Leu His Phe Val Glu Leu Gly 
                245                 250                 255     


Ser Gly Pro Ala Val Cys Leu Cys His Gly Phe Pro Glu Ser Trp Tyr 
            260                 265                 270         


Ser Trp Arg Tyr Gln Ile Pro Ala Leu Ala Gln Ala Gly Tyr Arg Val 
        275                 280                 285             


Leu Ala Met Asp Met Lys Gly Tyr Gly Glu Ser Ser Ala Pro Pro Glu 
    290                 295                 300                 


Ile Glu Glu Tyr Cys Met Glu Val Leu Cys Lys Glu Met Val Thr Phe 
305                 310                 315                 320 


Leu Asp Lys Leu Gly Leu Ser Gln Ala Val Phe Ile Gly His Asp Trp 
                325                 330                 335     


Gly Gly Met Leu Val Trp Tyr Met Ala Leu Phe Tyr Pro Glu Arg Val 
            340                 345                 350         


Arg Ala Val Ala Ser Leu Asn Thr Pro Phe Ile Pro Ala Asn Pro Asn 
        355                 360                 365             


Met Ser Pro Leu Glu Ser Ile Lys Ala Asn Pro Val Phe Asp Tyr Gln 
    370                 375                 380                 


Leu Tyr Phe Gln Glu Pro Gly Val Ala Glu Ala Glu Leu Glu Gln Asn 
385                 390                 395                 400 


Leu Ser Arg Thr Phe Lys Ser Leu Phe Arg Ala Ser Asp Glu Ser Val 
                405                 410                 415     


Leu Ser Met His Lys Val Cys Glu Ala Gly Gly Leu Phe Val Asn Ser 
            420                 425                 430         


Pro Glu Glu Pro Ser Leu Ser Arg Met Val Thr Glu Glu Glu Ile Gln 
        435                 440                 445             


Phe Tyr Val Gln Gln Phe Lys Lys Ser Gly Phe Arg Gly Pro Leu Asn 
    450                 455                 460                 


Trp Tyr Arg Asn Met Glu Arg Asn Trp Lys Trp Ala Cys Lys Ser Leu 
465                 470                 475                 480 


Gly Arg Lys Ile Leu Ile Pro Ala Leu Met Val Thr Ala Glu Lys Asp 
                485                 490                 495     


Phe Val Leu Val Pro Gln Met Ser Gln His Met Glu Asp Trp Ile Pro 
            500                 505                 510         


His Leu Lys Arg Gly His Ile Glu Asp Cys Gly His Trp Thr Gln Met 
        515                 520                 525             


Asp Lys Pro Thr Glu Val Asn Gln Ile Leu Ile Lys Trp Leu Asp Ser 
    530                 535                 540                 


Asp Ala Arg Asn Pro Pro Val Val Ser Lys Met 
545                 550                 555 


<210> 3
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (3)..(21)
<223> a, c, t, g, unknown or other

<400> 3
aannnnnnnn nnnnnnnnnn ntt                                               23


